AgomAb director Epstein buys 5,000 shares
AgomAb Therapeutics NV director David R. Epstein reported a purchase of 5,000 shares at $8.90 each, for $44,500, in a Form 4 filed Oct. 8, 2026.
AgomAb Therapeutics NV director David R. Epstein reported a purchase of 5,000 shares at $8.90 each, for $44,500, in a Form 4 filed Oct. 8, 2026.